Inventor · disambiguated record
Liliane Goetsch
Also filed as: GOETSCH LILIANE
44 granted patents·25 pending applications·372 citations·filing 2001–2022
98Inventor score
Files withGOETSCH LILIANE31PF MEDICAMENT29MERCK SHARP & DOHME3HAEUW JEAN-FRANCOIS2BEAU-LARVOR CHARLOTTE1
Top patents by PatentIndex Score
69 records- 0195US8545839B2Anti-c-Met antibodyGOETSCH LILIANE·Filed 2010·Granted Oct 1, 2013·20 cites·33 claims
- 0295US8329173B2Antibodies inhibiting c-Met dimerization and uses thereofGOETSCH LILIANE·Filed 2008·Granted Dec 11, 2012·24 cites·27 claims
- 0394US8344112B2IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2008·Granted Jan 1, 2013·41 cites·12 claims
- 0493US9469691B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2014·Granted Oct 18, 2016·8 cites·29 claims
- 0593US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 0692US8741290B2Anti-cMet antibodyGOETSCH LILIANE·Filed 2009·Granted Jun 3, 2014·15 cites·27 claims
- 0791US9375425B2Combination of a C-Met antagonist and an aminoheteroaryl compound for the treatment of cancerGOETSCH LILIANE·Filed 2015·Granted Jun 28, 2016·4 cites·17 claims
- 0891US9011865B2Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancerPF MEDICAMENT·Filed 2013·Granted Apr 21, 2015·6 cites·17 claims
- 0990US8765128B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted Jul 1, 2014·8 cites·14 claims
- 1090US8747850B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted Jun 10, 2014·6 cites·56 claims
- 1190US8673302B2Anti-cMet antibody and its use for the detection and the diagnosis of cancerGOETSCH LILIANE·Filed 2010·Granted Mar 18, 2014·9 cites·23 claims
- 1289US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 1388US10633448B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Apr 28, 2020·4 cites·21 claims
- 1488US8071730B2Anti-JAM-A antibodiesGOETSCH LILIANE·Filed 2008·Granted Dec 6, 2011·7 cites·21 claims
- 1587US10202458B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Feb 12, 2019·9 cites·24 claims
- 1687US9107907B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Aug 18, 2015·6 cites·30 claims
- 1787US8889832B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Nov 18, 2014·6 cites·55 claims
- 1887US8871910B2Antibodies inhibiting c-Met dimerization, and uses thereofGOETSCH LILIANE·Filed 2012·Granted Oct 28, 2014·6 cites·55 claims
- 1987US8871909B2Antibodies inhibiting c-Met dimerization and uses thereofGOETSCH LILIANE·Filed 2012·Granted Oct 28, 2014·6 cites·55 claims
- 2087US8361461B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2006·Granted Jan 29, 2013·8 cites·27 claims
- 2187US8124079B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2010·Granted Feb 28, 2012·8 cites·8 claims
- 2286US8729249B2Anti-cMET antibodyGOETSCH LILIANE·Filed 2012·Granted May 20, 2014·4 cites·51 claims
- 2386US7854930B2Anti-igf-ir antibodies and uses thereofPF MEDICAMENT·Filed 2005·Granted Dec 21, 2010·7 cites·8 claims
- 2485US10858423B2Composition for the treatment of IGF-1R expressing cancerPF MEDICAMENT·Filed 2016·Granted Dec 8, 2020·3 cites·14 claims
- 2585US8168410B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2011·Granted May 1, 2012·4 cites·14 claims
- 2685US8101180B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2009·Granted Jan 24, 2012·5 cites·12 claims
- 2785US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 2884US11219693B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2019·Granted Jan 11, 2022·1 cites·26 claims
- 2984US9173962B2Antigen binding protein and its use as addressing product for the treatment of cancerBEAU-LARVOR CHARLOTTE·Filed 2013·Granted Nov 3, 2015·11 cites·8 claims
- 3084US8623359B2Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancerGOETSCH LILIANE·Filed 2009·Granted Jan 7, 2014·4 cites·17 claims
- 3183US2023406940A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2022·Application pending·0 cites
- 3282US11365259B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2018·Granted Jun 21, 2022·2 cites·26 claims
- 3382US10314921B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Jun 11, 2019·3 cites·23 claims
- 3473US2019359717A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 3571US10161930B2Antigen binding protein and its use as addressing product for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Dec 25, 2018·1 cites·12 claims
- 3671US9624308B2Antigen binding proteinsPF MEDICAMENT·Filed 2013·Granted Apr 18, 2017·1 cites·14 claims
- 3771US8178096B2Use of an anti-CD151 antibody in the treatment of cancerHAEUW JEAN-FRANCOIS·Filed 2007·Granted May 15, 2012·1 cites·11 claims
- 3870US9689862B2Antigen binding protein and its use as addressing product for the treatment of cancerPF MEDICAMENT·Filed 2012·Granted Jun 27, 2017·1 cites·15 claims
- 3970US2021087278A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2020·Application pending·0 cites
- 4069US2018142024A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2017·Application pending·0 cites
- 4167US9676839B2Process for the modulation of the antagonistic activity of a monoclonal antibodyGOETSCH LILIANE·Filed 2009·Granted Jun 13, 2017·0 cites·7 claims
- 4267US8241646B2Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their usesGOETSCH LILIANE·Filed 2007·Granted Aug 14, 2012·0 cites·23 claims
- 4367US2008193445A1Novel anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2007·Application pending·0 cites
- 4466US2017218071A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2016·Application pending·0 cites
- 4561US2014115727A1NOVEL ANTI-cMET ANTIBODYGOETSCH LILIANE·Filed 2013·Application pending·0 cites
- 4659US11661457B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted May 30, 2023·0 cites·23 claims
- 4758US2015078996A1Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4858US2015079080A1Novel anti-igf-ir antibodies and uses thereofMERCK SHARP & DOHME CORP ; INST DE RECH PIERRE FABRE·Filed 2014·Application pending·0 cites
- 4958US2013273031A1Novel anti-igf-ir antibodies and uses thereofINST RECH PIERRE FABRE·Filed 2013·Application pending·0 cites
- 5057US8808667B2Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their usesGOETSCH LILIANE·Filed 2012·Granted Aug 19, 2014·0 cites·22 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Liliane Goetsch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →